Pliant Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $45.4M | $71.2M | $63.2M | $33.7M | $51.7M | $50.9M | $85.8M |
| Accounts Receivable | — | — | $0 | $2.0M | $2.0M | $9.3M | $7.1M |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $196.4M | $362.3M | $505.5M | $340.3M | $209.4M | $290.8M | $111.9M |
| Property, Plant & Equipment | $2.9M | $5.5M | $3.6M | $4.5M | $4.6M | $4.3M | $4.1M |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $225.2M | $396.9M | $512.2M | $350.6M | $221.2M | $295.5M | $119.1M |
| Liabilities | |||||||
| Accounts Payable | $480.0K | $6.0M | $4.5M | $1.6M | $3.0M | $2.0M | $1.3M |
| Total Current Liabilities | $16.4M | $33.2M | $28.5M | $23.9M | $16.8M | $11.6M | $8.2M |
| Long-Term Debt | $0 | $30.2M | $10.1M | $9.9M | $0 | — | — |
| Total Liabilities | $44.0M | $92.9M | $38.6M | $37.3M | $22.2M | $12.5M | $9.1M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-859.4M | $-710.1M | $-499.7M | $-338.4M | $-215.1M | $-117.8M | $-76.3M |
| Total Stockholders' Equity | $181.2M | $304.1M | $473.6M | $313.3M | $199.1M | $283.1M | $-76.3M |